David H. Katz
25Patents
13h-index
16Co-inventors
78Inventor score
Filing activity: Feb 3, 1977 → Jul 16, 2002
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4943522A | Lateral flow, non-bibulous membrane assay protocols | Emerging Cross-Sectional Technologies | 422 | Expired |
| US6585707B2 | Drug delivery device having improved adhesion and attachment system for drug delivery device | Human Necessities | 170 | Expired |
| US4874794A | Inflammatory disease treatment | Human Necessities | 122 | Expired |
| US5952392A | Long-chain alcohols, alkanes, fatty acids and amides in the treatment of burns and viral inhibition | Human Necessities | 117 | Expired |
| US4496654A | Detection of HCG with solid phase support having avidin coating | Emerging Cross-Sectional Technologies | 94 | Expired |
| US4191668A | Induction of immunological tolerance | Emerging Cross-Sectional Technologies | 32 | Expired |
| US4220565A | Immunochemical conjugates: method and composition | Emerging Cross-Sectional Technologies | 31 | Expired |
| US5534554A | Sucrose ester-C20 to C28 alcohol formulations | Human Necessities | 29 | Expired |
| US4276206A | Immunochemical conjugates: method and composition | Emerging Cross-Sectional Technologies | 20 | Expired |
| US4222907A | Induction of immunological tolerance | Emerging Cross-Sectional Technologies | 17 | Expired |
| US4253996A | Immunochemical conjugates: method and composition | Emerging Cross-Sectional Technologies | 16 | Expired |
| US5166219A | Systemic anti-inflammatory treatment | Human Necessities | 14 | Expired |
| US4388441A | Induction of immunological tolerance | Human Necessities | 13 | Expired |
| US4253995A | Immunochemical conjugates: method and composition | Emerging Cross-Sectional Technologies | 10 | Expired |
| US5071879A | Systemic antiviral treatment | Human Necessities | 9 | Expired |
| US5194451A | Systemic anti-inflammatory treatment | Human Necessities | 9 | Expired |
| US5070107A | Systemic antiviral treatment | Human Necessities | 8 | Expired |
| US4950469A | D-GL conjugate therapy | Emerging Cross-Sectional Technologies | 7 | Expired |
| US5948822A | Treatment of hyperproliferative skin disorders with C18 to C26 alphatic alcohols | Human Necessities | 6 | Expired |
| US4950713A | Conjugates of D-glutamic acid: D-lysine copolymer and certain biochemicals | Emerging Cross-Sectional Technologies | 6 | Expired |
| US5017648A | D-GL conjugate therapy | Human Necessities | 5 | Expired |
| US6440980B1 | Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs | Chemistry; Metallurgy | 4 | Expired |
| US7091190B2 | Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs | Chemistry; Metallurgy | 3 | Expired |
| US6313179A | Treatment of hyperproliferative skin disorders with C18 to C20 aliphatic alcohols | Human Necessities | 1 | Expired |
| US6270746A | Assay for the identification of IgE antibody suppressors | Physics | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.